Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
Other Current Assets
Bristol-Myers Squibb Co
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Current Assets
$2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Current Assets
$4.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-6%
|
|
Pfizer Inc
NYSE:PFE
|
Other Current Assets
$5.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-5%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Current Assets
$7.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
Zoetis Inc
NYSE:ZTS
|
Other Current Assets
$442m
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Current Assets
$6.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
See Also
What is Bristol-Myers Squibb Co's Other Current Assets?
Other Current Assets
2B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Other Current Assets amounts to 2B USD.
What is Bristol-Myers Squibb Co's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-1%
Over the last year, the Other Current Assets growth was 8%. The average annual Other Current Assets growth rates for Bristol-Myers Squibb Co have been -18% over the past three years , 5% over the past five years , and -1% over the past ten years .